Cambodia vs Tanzania, United Republic of: Tuberculosis treatment success rate
Cambodia
96.0%
in 2023
Tanzania, United Republic of
96.0%
in 2023
Cambodia rank
16th
Tanzania, United Republic of rank
16th
Tuberculosis treatment success rate over time
- Cambodia
- Tanzania, United Republic of
How they compare
Cambodia currently reports 96.0% against 96.0% in Tanzania, United Republic of, a difference of 0.0%.
The two have swapped places 3 times across 30 shared years of data; in 1994 it was Cambodia ahead.
Cambodia ranks 16th and Tanzania, United Republic of ranks 16th of 206 countries.
Across the 4 decades both report, Cambodia averaged higher in 3 and Tanzania, United Republic of in 1.
Head to head by decade
| Decade | Cambodia | Tanzania, United Republic of | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 91.3% | 76.7% | 14.7% | Cambodia |
| 2000s | 92.3% | 83.4% | 8.9% | Cambodia |
| 2010s | 93.5% | 90.3% | 3.2% | Cambodia |
| 2020s | 95.8% | 96.0% | 0.2% | Tanzania, United Republic of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate, Cambodia or Tanzania, United Republic of?
- Cambodia, at 96.0% against 96.0% in Tanzania, United Republic of as of 2023.
- What is the difference in tuberculosis treatment success rate between Cambodia and Tanzania, United Republic of?
- 0.0%, with Cambodia ahead.
- How many years of comparable data are there for Cambodia and Tanzania, United Republic of?
- 30 years are reported by both, from 1994 to 2023.
- How do Cambodia and Tanzania, United Republic of rank globally for tuberculosis treatment success rate?
- Cambodia ranks 16th and Tanzania, United Republic of ranks 16th of 206 countries.
- Where does this data come from?
- WHO (2025) β with minor processing by Our World in Data, published as Tuberculosis treatment success rate. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Treatment success rate among new and relapse cases.